Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for NAF collection in breast cancer
NCT02127073Phase 2Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2015
- Primary completion
- Jan 2017
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in breast cancer, ductal carcinoma in situ (DCIS), sponsored by Montefiore Medical Center. Started Jan 2015; status: terminated.
02
Drugs
oxytocin nasal spray
03
Conditions
breast cancerductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT02127073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127073.